Common use of Biological Material Clause in Contracts

Biological Material. 2.3.1. As between the parties hereto, subject to the the terms herein, including without limitation, the license granted to Licensee pursuant to Section 2.1 and any Sublicenses granted to Sublicensees pursuant to Section 2.2, all rights, title and interest in and to all Biological Material, and any intellectual property applying thereto, shall be owned solely and exclusively by Harvard. 2.3.2. Licensee shall not use Biological Material other than in accordance with the rights expressly granted to it hereunder. Except in connection with Sublicenses granted pursuant to Section 2.2, Licensee shall not sell or otherwise transfer any Biological Material to any third party. 2.3.3. The Biological Material is provided only for use in animals or in vitro. THE BIOLOGICAL MATERIAL SHALL NOT BE USED IN HUMANS. 2.3.4. Licensee shall inform Harvard’s Office of Technology Development (at 0000 Xxxxxxxxxxxxx Xxxxxx, Xxxxxxx X. and Xxxxx X. Xxxxx Xxxxxx Xxxxxx, Xxxxx 000, Xxxxxxxxx, XX 00000, (000) 000-0000, Attn: Chief Technology Development Officer) of any Biological Material created by Licensee that is different from, and a modification to, the Biological Material listed in Exhibit 1.3, and upon Harvard’s request, shall provide samples of such material to Harvard.

Biological Material. 2.3.1. As between the parties hereto, subject to the the terms herein, including without limitation, the license granted to Licensee pursuant to Section 2.1 and any Sublicenses granted to Sublicensees pursuant to Section 2.2, all rights, title and interest in and to all Biological Material, and any intellectual property applying thereto, shall be owned solely and exclusively by Harvard. 2.3.2. Licensee shall not use Biological Material other than in accordance with the rights expressly granted to it hereunder. Except in connection with Sublicenses granted pursuant to Section 2.2, Licensee shall not sell or otherwise transfer any Biological Material to any third party. 2.3.3. The Biological Material is provided only for use in animals or in vitro. THE BIOLOGICAL MATERIAL SHALL NOT BE USED IN HUMANS. 2.3.4. Licensee shall inform Harvard’s Office of Technology Development (at 0000 1000 Xxxxxxxxxxxxx Xxxxxx, Xxxxxxx Rxxxxxx X. and Xxxxx Sxxxx X. Xxxxx Xxxxxx XxxxxxCampus Center, Xxxxx Sxxxx 000, Xxxxxxxxx, XX 00000, (000) 000-0000, Attn: Chief Technology Development Officer) of any Biological Material created by Licensee that is different from, and a modification to, the Biological Material listed in Exhibit 1.3, and upon Harvard’s request, shall provide samples of such material to Harvard. 2.3.5. Licensee shall deliver to Harvard between [**] and [**] of the product of Licensee’s expansion of the Biological Material, at Licensee’s expense, no later than August 15, 2016. 2.3.6. As between the parties hereto, all right, title and interest in and to all Viruses, Products, and any intellectual property applying thereto or to the production thereof, shall be owned solely and exclusively by Licensee. For the avoidance of doubt, nothing herein prohibits or is intended to prohibit the use of Products in humans.

Biological Material. 2.3.1. As between the parties hereto, subject to the the terms herein, including without limitation, the license granted to Licensee pursuant to Section 2.1 and any Sublicenses granted to Sublicensees pursuant to Section 2.2, all rights, title and interest in and to all Biological Material, and any intellectual property applying thereto, shall be owned solely and exclusively by Harvard. 2.3.2. Licensee shall not use Biological Material other than in accordance with the rights expressly granted to it hereunder. Except in connection with Sublicenses granted pursuant to Section 2.2, Licensee shall not sell or otherwise transfer any Biological Material to any third party. 2.3.3. The Biological Material is provided only for use in animals or in vitro. THE BIOLOGICAL MATERIAL SHALL NOT BE USED IN HUMANS. 2.3.4. Licensee shall inform Harvard’s Office of Technology Development (at 0000 Xxxxxxxxxxxxx Xxxxxx, Xxxxxxx X. and Xxxxx X. Xxxxx Xxxxxx Xxxxxx, Xxxxx 000, Xxxxxxxxx, XX 00000, (000) 000-0000, Attn: Chief Technology Development Officer) of any Biological Material created by Licensee that is different from, and a modification to, the Biological Material listed in Exhibit 1.3, and upon Harvard’s request, shall provide samples of such material to Harvard. 2.3.5. Licensee shall deliver to Harvard between [XXX] and [XXX] of the product of Licensee’s expansion of the Biological Material, at Licensee’s expense, no later than August 15, 2016. 2.3.6. As between the parties hereto, all right, title and interest in and to all Viruses, Products, and any intellectual property applying thereto or to the production thereof, shall be owned solely and exclusively by Licensee. For the avoidance of doubt, nothing herein prohibits or is intended to prohibit the use of Products in humans.

Biological Material. 2.3.1. 2.3.1 As between the parties hereto, subject to the the terms herein, including without limitation, the license granted to Licensee pursuant to Section 2.1 and any Sublicenses granted to Sublicensees pursuant to Section 2.2, all rights, title and interest in and to all Biological Material, and any intellectual property applying thereto, shall be owned solely and exclusively by Harvard. 2.3.2. 2.3.2 Licensee shall not use Biological Material other than in accordance with the rights expressly granted to it hereunder. Except in connection with Sublicenses granted pursuant to Section 2.2, Licensee shall not sell or otherwise transfer any Biological Material to any third party. 2.3.3. 2.3.3 The Biological Material is provided only for use in animals or in vitro. THE BIOLOGICAL MATERIAL SHALL NOT BE USED IN HUMANS. 2.3.4. 2.3.4 Licensee shall inform Harvard’s Office of Technology Development (at 0000 Xxxxxxxxxxxxx Xxxxxx, Xxxxxxx X. and Xxxxx X. Xxxxx Xxxxxx XxxxxxCampus Center, Xxxxx 000, Xxxxxxxxx, XX 00000, (000) 000-0000, Attn: Chief Technology Development Officer) of any Biological Material created by Licensee that is different from, and a modification to, the Biological Material listed in Exhibit 1.3, and upon Harvard’s request, shall provide samples of such material to Harvard. 2.3.5 As between the parties hereto, all right, title and interest in and to all Viruses, Products, and any intellectual property applying thereto or to the production thereof, shall be owned solely and exclusively by Licensee. For the avoidance of doubt, nothing herein prohibits or is intended to prohibit the use of Products in humans.

Biological Material. 2.3.1. As between the parties hereto, subject to the the terms herein, including without limitation, the license granted to Licensee pursuant to Section 2.1 and any Sublicenses granted to Sublicensees pursuant to Section 2.2, all rights, title and interest in and to all Biological Material, and any intellectual property applying thereto, shall be owned solely and exclusively by Harvard.. [XXX] CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. CONFIDENTIAL TREATMENT REQUESTED 2.3.2. Licensee shall not use Biological Material other than in accordance with the rights expressly granted to it hereunder. Except in connection with Sublicenses granted pursuant to Section 2.2, Licensee shall not sell or otherwise transfer any Biological Material to any third party. 2.3.3. The Biological Material is provided only for use in animals or in vitro. THE BIOLOGICAL MATERIAL SHALL NOT BE USED IN HUMANS. 2.3.4. Licensee shall inform Harvard’s Office of Technology Development (at 0000 Xxxxxxxxxxxxx Xxxxxx, Xxxxxxx X. and Xxxxx X. Xxxxx Xxxxxx Xxxxxx, Xxxxx 000, Xxxxxxxxx, XX 00000, (000) 000-0000, Attn: Chief Technology Development Officer) of any Biological Material created by Licensee that is different from, and a modification to, the Biological Material listed in Exhibit 1.3, and upon Harvard’s request, shall provide samples of such material to Harvard. 2.3.5. Licensee shall deliver to Harvard between [XXX] and [XXX] of the product of Licensee’s expansion of the Biological Material, at Licensee’s expense, no later than August 15, 2016. 2.3.6. As between the parties hereto, all right, title and interest in and to all Viruses, Products, and any intellectual property applying thereto or to the production thereof, shall be owned solely and exclusively by Licensee. For the avoidance of doubt, nothing herein prohibits or is intended to prohibit the use of Products in humans.